Marina Savic

Marina Savić, PhD

Full professor

Chair of Organic Chemistry

CONTACT

University of Novi Sad Faculty of Sciences

Department of Chemistry, Biochemistry and Environmental Protection

Office: 4/III, 15/V

Adress: Trg Dositeja Obradovića 3

21000 Novi Sad, Serbia

Tel:+ 381 21 485 2733

e-mail: marina.savic@dh.uns.ac.rs

SCOPUS Autor ID: 23986790200

ORCID: https://orcid.org/0000-0002-1019-3673

EDUCATION

  • 2013. PhD in Chemistry, Faculty of Sciences University of Novi Sad, Serbia
  • 2008. MSc in Chemistry, Faculty of Sciences University of Novi Sad, Serbia
  • 2003. BSc in Chemistry, Faculty of Sciences University of Novi Sad, Serbia

SCIENTIFIC AND ACADEMIC POSITIONS

  • 2026- today. Full professor, Faculty of Sciences University of Novi Sad, Serbia
  • 2021- 2026. Associate professor, Faculty of Sciences University of Novi Sad, Serbia
  • 2016-2021. Assistant professor, Faculty of Sciences University of Novi Sad, Serbia
  • 2014-2016. Research Associate, Faculty of Sciences University of Novi Sad, Serbia
  • 2009-2014. Research Assistant, Faculty of Sciences University of Novi Sad, Serbia
  • 2006-2009. Junior Researcher, Faculty of Sciences University of Novi Sad, Serbia.

TEACHING

  • Nomenclature of organic compounds
  • Organic chemistry II
  • Chemistry of new materials
  • Supramolecular chemistry
  • Chemistry of androgenic and antiandrogenic compounds
  • Chemistry of biologically active organic compounds

TEXTBOOKS

  • Savić, M. Fundamentals of Supramolecular Chemistry, University of Novi Sad, Faculty of Sciences, Novi Sad, 2025
  • Grbović, Lj., Ajduković, J., Nikolić, A., Savić, M., Pavlović, K., Oklješa A., Bjedov S. Organic chemistry practical textbook, Faculty of Sciences University of Novi Sad, Novi Sad, 2019, (In Serbian).

RESEARCH FIELDS

  • Organic chemistry
  • Organic synthesis
  • Synthesis and chemical modifications of new androstane derivatives as potentially biologically active compounds.

SELECTED PROJECTS

  • New Steroid Hormone Derivatives for the Treatment of Leishmaniasis, a bilateral cooperation project between the Republic of Serbia and the Republic of France within the “Pavle Savić” program; 2025–2026. Project leader: Dr. Jovana Ajduković.
  • Novel steroid derivatives for anticancer drug development, bilateral cooperation project between the Republic of Serbia and Republic of Austria, project number: 337-00-577/2021-09/27; project duration 2022-2024. Project leader: dr. Marina Savić
  • New steroid derivatives – potential chemotherapeutics, Provincial Secretariat for Higher Education and Scientific Research of the Autonomous Province of Vojvodina,  Serbia(2021-2024., 142-451-2667/2021-01), Project leader: dr. Marina Savić
  • Development of steroid derivatives of potential biomedical importance, Provincial Secretariat for Higher Education and Scientific Research of the Autonomous Province of Vojvodina,  Serbia (2021-2022., 142-451-2309/2021-01)
  • Organic chemistry in the profession and science, program activity Higher Education, the Ministry of Education, Science and Technological Development of the Republic of Serbia (2021-2022)
  • Synthesis, characterization and biological investigation of steroid derivatives and their molecular aggregates, Ministry of Education, Science and Technological Development of the Republic of Serbia (2011-2019)
  • Research Cooperation of the University of Szeged and the University of Novi Sad in Development of Anticancer Drug Compounds (RECODAC), Hungary-Serbia IPA Cross-border Co-operation Programme (2012-2014)
  • Synthesis and physical-chemical investigations of selected organic compounds of potential pharmacological significance, Ministry of Education, Science and Technological Development of the Republic of Serbia (2006-2010).

SELECTED PUBLICATIONS

  1. Jovana J. Ajduković, Ana Matošević, Anita Bosak, Strahinja Kovačević, Milica Karadžić Banjac, Ivana Z. Kuzminac, Andrea R. Nikolić, Marina P. Savić, Targeting cholinesterases with steroid hormone derivatives: Insights from In Vitro assays and molecular modeling, J. Steroid Biochem. 258, 106950 (2026).
  2. Tijana Lj. Šestić, Sofija S. Bekić, Maja A. Marinović, Marie Kvasnicová, Tereza Štenclová, Lucie Rárová, Andjelka S. Ćelić, Edward T. Petri, Jovana J. Ajduković, Miroslav Strnad, Marina P. Savić, Heterocyclic androstane derivatives targeting hormone-related cancers: Synthesis, bioactivity and docking studies, European Journal of Medicinal Chemistry 296, 117850 (2025).
  3. Ivana Z. Kuzminac, Andrea R. Nikolić, Marina P. Savić, Jovana J. Ajduković, Abiraterone and Galeterone, Powerful Tools Against Prostate Cancer: Present and Perspective, Pharmaceutics 16(11), 1401 (2024).
  4. Đorđe D. Janković, Tijana Lj. Šestić, Sofija S. Bekić, Marina P. Savić, Andjelka S. Ćelić, Julia Scholda, Florian Kopp, Maja A. Marinović, Edward T. Petri, Jovana J. Ajduković, Development of new steroid-based hydrazide and (thio)semicarbazide compounds with anticancer properties, J. Steroid Biochem. 242, 106545 (2024).
  5. Tijana Lj. Šestić, Jovana J. Ajduković, Sofija S. Bekić, Andjelka S. Ćelić, Sanja T. Stojanović, Stevo J. Najman, Maja A. Marinović, Edward T. Petri, Dušan Đ. Škorić, Marina P. Savić, Novel D-modified heterocyclic androstane derivatives as potential anticancer agents: Synthesis, characterization, in vitro and in silico studies, J. Steroid Biochem. 233, 106362 (2023).